Delivery Order SPE2DB20D3103-SPE2DB23FP2X2
- Not listed
- This federal contract award, valued at $1,182.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Testosterone Cypionate 200 mg/mL, a pharmaceutical product. The contract type is Delivery Order with a Firm Fixed Price pricing structure, and the period of performance runs through January 24, 2025. The contract does not have a set-aside designation,...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,888.00 firm fixed-price delivery order is for the supply of testosterone cypionate 200 mg/ml. The contract has an ultimate completion date of July 9, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $1,015.68 firm fixed-price delivery order contract is for the supply of testosterone cypionate 200 mg/ml medication. The contract has an ultimate completion date of October 27, 2023 and was awarded on October 26, 2023. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
- This federal contract award, valued at $1,416.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of Testosterone Cypionate 200 mg/mL, a testosterone replacement therapy medication. The contract has an ultimate completion date of March 7, 2025 and uses a Firm Fixed Price pricing type. It is not designated with a set-aside requirement, indicating...
- This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the delivery of 2,000 mg/10 ml vials of Testosterone Cypionate, a pharmaceutical product. The $1,440.10 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a major defense agency that procures medical supplies and equipment for the U.S. military. The contract has an ultimate completion date of September 23, 2024 and was awarded on September 20,...
- This federal contract award, valued at $1,212.07, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of testosterone cypionate 200 mg/mL, a specialty medication. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,458.32 firm fixed-price delivery order contract is for the supply of testosterone cypionate 200 mg/mL, a specialty medication. The contract has an ultimate completion date of December 18, 2024 and was awarded on December 17, 2024. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Testosterone Cypionate 200 mg/mL medication. The $2,295.00 firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) and has an ultimate completion date of May 11, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to...
- This federal contract award, valued at $1,698.33, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Testosterone Cypionate 200 mg/mL, a specialty medication, with a period of performance through January 12, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $2,280.00 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Testosterone Cypionate 200 mg/mL medication. This delivery order falls under a larger indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB23FP2X2Delivery Order
This contract award, valued at $1,943.88, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a division of the parent company Cencora, Inc. The contract is for the delivery of Testosterone Cypionate 200 mg/mL, a pharmaceutical product, to support DLA Troop Support Medical operations. The contract is a firm-fixed price delivery order with a period of performance extending through August 9, 2023. This award is not associated with a set-aside program, indicating open competition. As a major pharmaceutical distributor, Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 8/8/23 |